Acurx Pharmaceuticals（ACXP.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

公众及其他89.16%
机构投资者8.40%
个人与内部人士2.44%

主要股东

主要股东最新
股东
Armistice Capital LLC	3.13%	16.50 万	0.68%	+8.18 万	2026/04/20
3i Fund	2.35%	12.39 万	1.91%	+10.89 万	2026/04/20
David LuciCo-Founder, President, CEO, Corporate Secretary & Director	1.09%	5.74 万	0.14%	+1.00	2026/08/15
Robert DeLucciaCo-Founder & Executive Chairman	0.96%	5.07 万	0.12%	+0	2026/08/15
Vanguard Capital Management, LLC	0.90%	4.73 万	0.50%	+0	2026/06/30
Intracoastal Capital LLC	0.51%	2.69 万	0.51%	+2.69 万	2026/04/20
Geode Capital Management, LLC	0.50%	2.64 万	0.23%	+1,592.00	2026/06/30
Jane Street Group, LLC	0.30%	1.57 万	1.31%	-3.89 万	2026/06/30
Prospect Financial Services LLC	0.26%	1.38 万	0.15%	+0	2026/06/30
Robert ShawahCo-Founder & CFO	0.18%	9,460.00	0.02%	+0	2026/08/15
Morgan Stanley	0.14%	7,500.00	0.05%	+1,000.00	2026/06/30
Carl SailerIndependent Director	0.13%	7,109.00	0.02%	+0	2026/08/15
Orca Capital GmbH	0.11%	5,670.00	0.06%	+0	2025/01/15
Tower Research Capital Europe Limited	0.05%	2,744.00	0.02%	+1,713.00	2026/06/30
Wells Fargo & Company	0.04%	2,300.00	0.02%	+0	2026/06/30
Westside Investment Management, LLC	0.03%	1,650.00	0.02%	+0	2026/06/30
Hudson Bay Capital Management LP	0.03%	1,506.00	0.02%	+0	2025/01/15
Lanark Financial, Inc.	0.03%	1,500.00	0.02%	+0	2026/06/30
Joseph ScodariIndependent Director	0.03%	1,385.00	<0.01%	+0	2026/08/15
Jack DeanScientific Advisor & Independent Director	0.03%	1,377.00	<0.01%	+0	2026/08/15